@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NJSHJ61G-Z
  skos:prefLabel "Imidazolines"@fr, "Imidazolines"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-VMDVPGTM-0 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FG8LP9J8-Q
  skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BLDG6WP6-H
  skos:prefLabel "Adrenergic alpha-Antagonists"@en, "Antagonistes alpha-adrénergiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VMDVPGTM-0
  mesh:allowableQualifier jvr:-TJHVZCRZ-0, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-NKM836P1-M, jvr:-HQRFT0C6-B, jvr:-L6C0XPHT-4, jvr:-SBNWSM1T-R, jvr:-WK5F724J-1, jvr:-G30ZJ446-J, jvr:-G4R176S9-J, jvr:-BT300B3G-Q, jvr:-Q3979798-W, jvr:-XV06LPML-W, jvr:-NFTHND7Q-8, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-T9HQD7ST-J, jvr:-NHL3D2X0-S, jvr:-THHNVC7V-3, jvr:-D0F21513-5, jvr:-W6SQV79N-S, jvr:-FWD2BGQ0-9, jvr:-H7K65Q8S-Z ;
  skos:hiddenLabel "Chlorhydrate de tolazoline"@fr, "Divascol"@en, "Pridazole"@en, "Priscoline"@en, "Tolazoline Monohydrochloride"@en, "Tolazoline Hydrochloride"@en, "Priscol"@en ;
  skos:altLabel "Benzalolin"@en, "E669Z6S1JG"@fr, "E669Z6S1JG"@en, "1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-"@fr, "1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-"@en, "59-98-3 (Tolazoline)"@fr, "59-98-3 (Tolazoline)"@en, "CHH9H12AQ3"@fr, "CHH9H12AQ3"@en, "59-97-2 (mono-HCl)"@fr, "59-97-2 (mono-HCl)"@en ;
  mesh:pharmacologicalAction jvr:-K9FBN5C5-1, jvr:-BLDG6WP6-H, jvr:-FG8LP9J8-Q ;
  skos:inScheme jvr: ;
  dc:established "1966-01-01"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D014043> ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:definition "A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn."@en ;
  dc:modified "2017-05-24"^^xsd:date ;
  skos:broader jvr:-NJSHJ61G-Z ;
  skos:prefLabel "Tolazoline"@en, "Tolazoline"@fr .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .